vs
STANDARD BIOTOOLS INC.（LAB）与Star Holdings（STHO）财务数据对比。点击上方公司名可切换其他公司
Star Holdings的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$25.4M vs $19.6M），Star Holdings净利率更高（-75.5% vs -177.4%，领先101.9%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -22.6%），过去两年Star Holdings的营收复合增速更高（-0.2% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
蓝星有限公司是一家印度跨国家电企业，总部位于孟买，主营空调、商用制冷以及机电工程业务，是印度本土市场规模第二大的空调领域本土企业。
LAB vs STHO — 直观对比
营收规模更大
STHO
是对方的1.3倍
$19.6M
营收增速更快
LAB
高出11.1%
-22.6%
净利率更高
STHO
高出101.9%
-177.4%
两年增速更快
STHO
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $25.4M |
| 净利润 | $-34.7M | $-19.1M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -91.7% |
| 净利率 | -177.4% | -75.5% |
| 营收同比 | -11.5% | -22.6% |
| 净利润同比 | -28.8% | 81.3% |
| 每股收益（稀释后） | $-0.09 | $-1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABSTHO
| Q4 25 | — | $25.4M | ||
| Q3 25 | $19.6M | $28.1M | ||
| Q2 25 | $21.8M | $42.1M | ||
| Q1 25 | $40.8M | $14.6M | ||
| Q4 24 | — | $32.8M | ||
| Q3 24 | $22.1M | $24.6M | ||
| Q2 24 | $22.5M | $30.6M | ||
| Q1 24 | $45.5M | $25.4M |
净利润LABSTHO
| Q4 25 | — | $-19.1M | ||
| Q3 25 | $-34.7M | $1.8M | ||
| Q2 25 | $-33.5M | $-39.3M | ||
| Q1 25 | $-26.0M | $-7.6M | ||
| Q4 24 | — | $-102.6M | ||
| Q3 24 | $-26.9M | $91.9M | ||
| Q2 24 | $-45.7M | $-27.1M | ||
| Q1 24 | $-32.2M | $-49.0M |
毛利率LABSTHO
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABSTHO
| Q4 25 | — | -91.7% | ||
| Q3 25 | -168.5% | 1.0% | ||
| Q2 25 | -118.1% | -94.5% | ||
| Q1 25 | -80.8% | -55.0% | ||
| Q4 24 | — | -314.1% | ||
| Q3 24 | -120.9% | — | ||
| Q2 24 | -134.5% | -91.5% | ||
| Q1 24 | -132.2% | -192.6% |
净利率LABSTHO
| Q4 25 | — | -75.5% | ||
| Q3 25 | -177.4% | 6.4% | ||
| Q2 25 | -153.7% | -93.5% | ||
| Q1 25 | -63.8% | -52.0% | ||
| Q4 24 | — | -313.1% | ||
| Q3 24 | -122.0% | 374.3% | ||
| Q2 24 | -203.3% | -88.8% | ||
| Q1 24 | -70.6% | -192.6% |
每股收益（稀释后）LABSTHO
| Q4 25 | — | $-1.52 | ||
| Q3 25 | $-0.09 | $0.14 | ||
| Q2 25 | $-0.09 | $-2.95 | ||
| Q1 25 | $-0.07 | $-0.57 | ||
| Q4 24 | — | $-7.69 | ||
| Q3 24 | $-0.07 | $6.90 | ||
| Q2 24 | $-0.12 | $-2.04 | ||
| Q1 24 | $-0.27 | $-3.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $50.1M |
| 总债务越低越好 | — | $268.7M |
| 股东权益账面价值 | $399.7M | $251.8M |
| 总资产 | $539.6M | $570.2M |
| 负债/权益比越低杠杆越低 | — | 1.07× |
8季度趋势，按日历期对齐
现金及短期投资LABSTHO
| Q4 25 | — | $50.1M | ||
| Q3 25 | $129.4M | $40.6M | ||
| Q2 25 | $158.6M | $44.2M | ||
| Q1 25 | $150.9M | $30.3M | ||
| Q4 24 | — | $35.0M | ||
| Q3 24 | $210.6M | $45.0M | ||
| Q2 24 | $269.8M | $48.3M | ||
| Q1 24 | $287.1M | $45.7M |
总债务LABSTHO
| Q4 25 | — | $268.7M | ||
| Q3 25 | — | $259.3M | ||
| Q2 25 | — | $245.4M | ||
| Q1 25 | — | $231.5M | ||
| Q4 24 | — | $217.3M | ||
| Q3 24 | $55.2M | $201.2M | ||
| Q2 24 | $55.1M | $197.2M | ||
| Q1 24 | $55.0M | $195.0M |
股东权益LABSTHO
| Q4 25 | — | $251.8M | ||
| Q3 25 | $399.7M | $275.4M | ||
| Q2 25 | $424.5M | $276.1M | ||
| Q1 25 | $454.6M | $316.1M | ||
| Q4 24 | — | $324.3M | ||
| Q3 24 | $489.3M | $427.5M | ||
| Q2 24 | $510.3M | $335.3M | ||
| Q1 24 | $577.3M | $362.4M |
总资产LABSTHO
| Q4 25 | — | $570.2M | ||
| Q3 25 | $539.6M | $595.9M | ||
| Q2 25 | $557.0M | $589.9M | ||
| Q1 25 | $579.6M | $618.2M | ||
| Q4 24 | — | $608.7M | ||
| Q3 24 | $681.5M | $696.5M | ||
| Q2 24 | $708.7M | $601.0M | ||
| Q1 24 | $777.7M | $622.9M |
负债/权益比LABSTHO
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 0.94× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | 0.11× | 0.47× | ||
| Q2 24 | 0.11× | 0.59× | ||
| Q1 24 | 0.10× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-11.7M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABSTHO
| Q4 25 | — | $-11.7M | ||
| Q3 25 | $-22.2M | $5.3M | ||
| Q2 25 | $-20.7M | $-2.6M | ||
| Q1 25 | $-30.3M | $-6.3M | ||
| Q4 24 | — | $-31.3M | ||
| Q3 24 | $-27.9M | $-3.8M | ||
| Q2 24 | $-39.0M | $-6.4M | ||
| Q1 24 | $-62.5M | $-14.2M |
自由现金流LABSTHO
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABSTHO
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
资本支出强度LABSTHO
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
现金转化率LABSTHO
| Q4 25 | — | — | ||
| Q3 25 | — | 2.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
STHO
| Land Development | $13.0M | 51% |
| Other Income Revenue | $9.3M | 37% |
| Operating Lease Income | $2.0M | 8% |
| Other | $1.2M | 5% |
